Navigation Links
Discovery of key protein's shape could lead to improved bacterial pneumonia vaccine

Scientists at St. Jude Children's Research Hospital have discovered that the shape of a protein on the surface of pneumonia bacteria helps these germs invade the human bloodstream. This finding, published Dec. 16 online by the EMBO Journal, could help scientists develop a vaccine that is significantly more effective at protecting children against the disease. The St. Jude researchers determined the shape of a large, paddle-like molecule that Streptococcus pneumoniae bacteria use to latch onto cells lining the throat and lungs. The protein, called CbpA, binds to a molecule on the cell called pIgR, which takes antibodies from the bloodstream on one side of the cell and transports them to the other side. There it releases the antibody at the lining of the throat and lungs. If a pneumococcus bacterium is hovering on the lining of the respiratory tract, this germ binds to pIgR and pushes this antibody shuttle back through the cell to the bloodstream. Once at the other side of the cell, the pneumococcus breaks free of pIgR and enters the blood, where it can multiply and infect the body.

S. pneumoniae is the only bacterium known to use CbpA to invade human cells by binding to pIgR, according to Richard W. Kriwacki, Ph.D., associate member of St. Jude Structural Biology. Kriwacki is senior author of the EMBO Journal report. “The fact that we now know the structure of this important protein means we can begin to develop a vaccine that is more effective in children than those that are currently available,?Kriwacki said. Elaine Tuomanen, M.D., chair of Infectious Diseases and director of the Children’s Infection Defense Center at St. Jude, is co-author of the EMBO Journal paper. “Using CbpA as the key part of a new vaccine against S. pneumoniae would solve a problem that now hinders our ability to protect children from this infection,?Tuomanen said. Current pneumonia vaccines designed to protect adults against more than two dozen strains of S. pneumoniae do not work in
'"/>

Source:St. Jude Children's Research Hospital


Page: 1 2 3

Related biology news :

1. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
2. UCSD Discovery Shows How Embryonic Stem Cells Perform Quality Control Inspections
3. Discovery Could Lead To Novel Approaches In HIV Treatment
4. Discovery Promises Simpler Therapy for Sickle Cell Disease
5. Discovery may lead to better Candidiasis drug
6. Protein Discovery Could Unlock The Secret To Better TB Treatment
7. Discovery clarifies role of peptide in biological clock
8. Eliminate Data Analysis Bottlenecks in Drug Discovery
9. Discovery of New Dopamine Action May Yield Alternative Psychiatric Drugs
10. Discovery could be key to bioterrorism defense
11. Discovery of an American salamander where it shouldnt be: Korea

Post Your Comments:
(Date:11/3/2009)...ecutives in 35 of the top Fortune 500 companies we...es" in 2008, according to a new type of theoretica...her to determine fair CEO compensation. , "One o...nce issues of the day is how to determine fair pay...n, a professor of chemical engineering. "The propo...
(Date:11/3/2009)...ew and diverse types of garlic is on the rise. Fue...foods" movement, interest in world cuisines, and w...fits, demand for high-quality, locally grown garli... grocery stores in carry the familiar white, "soft...ties of "hardneck" garlic in colorful hues of purp...
(Date:11/3/2009)...ixed reputation. Their delicate, colorful flowers ...home gardeners and growers. But the striking plant...ecipe of light, moisture, warm temperatures, high ...african violets to grow and flower. , A recently...d Janet C. Cole from the Department of Horticultur...
Breaking Biology News(10 mins):New theory on fairness in economics targets CEO pay 2New theory on fairness in economics targets CEO pay 3New theory on fairness in economics targets CEO pay 4Sustainably grown garlic 2Sustainably grown garlic 3For African violets, 'hands off' means healthier 2The Hanover Launches New Insurance Option to Protect Family Members in Assisted Living Facilities 52000 1The Hanover Launches New Insurance Option to Protect Family Members in Assisted Living Facilities 52000 2The Hanover Launches New Insurance Option to Protect Family Members in Assisted Living Facilities 52000 3Encorium Group Completes Sale of its U S Business to Pierrel Research USA 3B Announces Management Changes 13076 1Encorium Group Completes Sale of its U S Business to Pierrel Research USA 3B Announces Management Changes 13076 2Encorium Group Completes Sale of its U S Business to Pierrel Research USA 3B Announces Management Changes 13076 3Encorium Group Completes Sale of its U S Business to Pierrel Research USA 3B Announces Management Changes 13076 4Ted Karkus Named CEO of The Quigley Corporation 3B Robert V Cuddihy Jr Named Chief Operating Officer 51991 1Ted Karkus Named CEO of The Quigley Corporation 3B Robert V Cuddihy Jr Named Chief Operating Officer 51991 2Ted Karkus Named CEO of The Quigley Corporation 3B Robert V Cuddihy Jr Named Chief Operating Officer 51991 3Ted Karkus Named CEO of The Quigley Corporation 3B Robert V Cuddihy Jr Named Chief Operating Officer 51991 4
...t contain high levels of action, such as Unreal To...earchers at the University of Rochester have shown...ew hours a day over the course of a month improved...letters presented in clutter—a visual acuity test ...ics. , In essence, playing video game improves y...
...l team led by researchers from the National Human ...ional Institutes of Health (NIH), has identified a...all size in dogs. The findings appear in the April...tification and characterization of a key genetic v...s particularly exciting because the underlying gen...
...t St. Jude Children,s Research Hospital have disco...bute to the formation of pediatric acute lymphobla...ldren. The discovery not only suggests novel metho... roadmap for the identification of unsuspected mut...ich immature white blood cells that normally devel...
Other Biology News:Action video games sharpen vision 20 percent 2Researchers identify gene involved in dog size 2Researchers identify gene involved in dog size 3Researchers identify gene involved in dog size 4Major gene study uncovers secrets of leukemia 2Major gene study uncovers secrets of leukemia 3
(Date:11/5/2009)..., AUSTIN, Texas, Nov. 5 SpineSm...GenOsteo, Inc. to co-develop a unique scaffold tha... Following evaluation of several commercial produ...tment, the company believes the GenOsteo scaffold ... that creates a unique and ideal environment for t...
(Date:11/5/2009)... Brooke Sanders brings a n...vine, CA (PRWEB) November 5, 2009 -- Professional ...ng reprographics company is pleased to present Bro...ny as their graphics/PR specialist. The addition o...onsistent growth within Professional Reprographics...
(Date:11/4/2009)..., PETERSBURG, Va., Nov. 4 /PRNewswire-FirstCall...nounced today that the company plans to introduce ...ts subsidiary, Rock Creek Pharmaceuticals, for wor...nVentiv Health, Inc . (Nasdaq: VTIV). inVentiv H... solutions for every stage of the product lifecycl...
(Date:11/4/2009)..., ,, NORRISTOWN, Pa., Nov. 4 /PRNewswire...ceutical solutions company, today announced that i...search , a contract research organization that sp...es, to further extend its business development cap... expertise of industry veteran Robert Westbrook, C...
Breaking Biology Technology:SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 2Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 3Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 4Emerson Resources Forges Strategic Partnership with Bio Research 2
...Adverse Toxic Effects, ATLANTA, Nov. 10 Potentia...ompany developing medicines for the treatment of,a...hase I data last week,during the Retina Subspecial...AO) Annual Meeting in Atlanta, GA. The data was fr...POT-4 Therapy for Patients with Neovascular,Age-Re...
...and Public Health Care ... to help government,entities, hospitals and public...mmunization season, Sentry Logistic Solutions is a...r storage and handling of vaccine,materials. In or...oducts,vaccine storage and distribution functions ...
...sdaq: NGSX ), a biopharmaceutical company focused...gement therapies, announced today that,Anthony DiT...heduled to,present at the Rodman & Renshaw 10th An...sday, November 11, 2008. Mr. DiTonno and Stephen G...ilable to respond to questions,during the breakout...
Other Biology Technology:Potentia Pharmaceuticals' Drug Candidate for Age-Related Macular Degeneration Shows Positive Safety Profile in Phase I Clinical Trial 2Potentia Pharmaceuticals' Drug Candidate for Age-Related Macular Degeneration Shows Positive Safety Profile in Phase I Clinical Trial 3Sentry Logistic Solutions Offers Outsourced Vaccine Storage & Distribution Service 2Sentry Logistic Solutions Offers Outsourced Vaccine Storage & Distribution Service 3NeurogesX to Present at Rodman & Renshaw 10th Annual Healthcare Conference 2NeurogesX to Present at Rodman & Renshaw 10th Annual Healthcare Conference 3
Bromophenol Blue sodium salt from Sigma-Aldrich
DAPI from KPL
LV-2080 Solvent Switching Valve from JASCO
GelCode Color Silver Stain Kit from Pierce Biotechnology, Inc.
Biology Products: